Prof Liang-Xi Xie is a master supervisor and chief physician. He received his doctoral degree in 2008 and went to Stanford University Cancer Center as a visiting scholar in 2011. He was one of the 2016 Guangdong Provincial Organization Department "Sailing Plan-Training Senior Talents". Currently he is the director of Department of Radiotherapy of Xiang'an Hospital of Xiamen University currently and member of the Professor Committee of Xiamen University. He mainly engaged in the research of precise radiotherapy technology for solid tumors and the mechanism of tumor metastasis. He presided over 3 national, provincial and ministerial scientific research projects, and published more than 10 SCI-listed papers.

Selected publications

1. Xie WJ, Wu X, Xue RL, Lin XY, Kidd EA, Yan SM, Zhang YH, Zhai TT, Lu JY, Wu LL, Zhang H, Huang HH, Chen ZJ, Li DR, Xie LX. More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix, Int J Radiat Oncol Biol Phys, 2015, 91(1): 206-12.

2. Lu JY, Cheung Michael Lok Man, Li M, Huang BT, Xie WJ, Xie LX. Dosimetric Evaluation of a Simple Planning Technique forImproving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer, PLos One,2 015, 10(7): e0129461.

3. Dong H, Xie L, Tang C, Chen S, Liu Q, Zhang Q, Zheng W, Zheng Z, Zhang H. Snail1 correlates with patient outcomes in E-cadherin-preservedgastroesophageal junction adenocarcinoma, Clin Transl Oncol, 2014, 16(9): 783-91.

4. Xie LX, Zhai TT, Yang LP, Eleano Yang, Zhang XH, Chen JY, Zhang H. Lymphangiogenesis and Prognostic Significanceof Vascular Endothelial Growth Factor-C (VEGF-C) in Gastroesophageal Junction Adenocarcinoma (GEJA), Int J Exp Pathol, 2013, 94(1): 39-46.